CureZone   Log On   Join
Trodelvy: Injection for intravenous infusion
rajupharma Views: 36
Published: 5 months ago

Trodelvy: Injection for intravenous infusion

The FDA approved the drug Sacituzumab govitecan hziy for the treatment of unresectable locally advanced or metastatic triple-negative Breast Cancer (mTNBC) and locally advanced or metastatic urothelial cancer (mUC). Sacituzumab govitecan hziy is sold under the brand name of Trodelvy. The medicine Trodelvy is supplied in single-dose vials of 180 mg for intravenous infusion. In India, Trodelvy price is reasonable, and one can find this medicine with several generic medicine suppliers. For more queries, call us at 1800-889-1064.

Printer-friendly version of this page Email this message to a friend
Alert Moderators
Report Spam or bad message  Alert Moderators on This GOOD Message

This Forum message belongs to a larger discussion thread. See the complete thread below. You can reply to this message!


Donate to CureZone

CureZone Newsletter is distributed in partnership with

Contact Us - Advertise - Stats

Copyright 1999 - 2023

0.234 sec, (1)